{"id":1012,"date":"2024-09-30T14:16:42","date_gmt":"2024-09-30T14:16:42","guid":{"rendered":"https:\/\/safire-consortium.org\/our-story\/"},"modified":"2025-01-14T11:09:28","modified_gmt":"2025-01-14T11:09:28","slug":"notre-histoire","status":"publish","type":"page","link":"https:\/\/safire-consortium.org\/fr\/notre-histoire\/","title":{"rendered":"Notre histoire"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1012\" class=\"elementor elementor-1012 elementor-34\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-24ddfcd e-flex e-con-boxed e-con e-parent\" data-id=\"24ddfcd\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b0d4411 e-flex e-con-boxed e-con e-parent\" data-id=\"b0d4411\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-e95c261 e-con-full e-flex e-con e-child\" data-id=\"e95c261\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5ca57dc elementor-widget elementor-widget-heading\" data-id=\"5ca57dc\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Notre histoire<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-404e679 elementor-widget elementor-widget-text-editor\" data-id=\"404e679\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>En 2022, <strong><a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240069404#:~:text=Based%20on%20a%20review%20of,the%20first%20trimester%20of%20pregnancy\" target=\"_blank\" rel=\"noopener\">l\u2019Organisation Mondiale de la Sant\u00e9 a r\u00e9vis\u00e9 ses lignes directrices<\/a><\/strong> pour recommander l\u2019art\u00e9m\u00e9ther-lum\u00e9fantrine (AL) plut\u00f4t que la quinine comme traitement privil\u00e9gi\u00e9 du paludisme non compliqu\u00e9 au cours du premier trimestre de la grossesse. N\u00e9anmoins, la s\u00e9curit\u00e9 et l\u2019efficacit\u00e9 d\u2019autres traitements combin\u00e9s \u00e0 base d\u2019art\u00e9misinine fr\u00e9quemment utilis\u00e9s restent sous-\u00e9tudi\u00e9es, ce qui pr\u00e9sente un manque de donn\u00e9es critique pour ce groupe de patients souvent n\u00e9glig\u00e9.<\/p><p>La <strong>strat\u00e9gie MiMBa, le registre des grossesses MiMBa<\/strong> et l\u2019\u00e9tude <strong>PYRAPREG<\/strong> ont \u00e9t\u00e9 lanc\u00e9s pour contribuer \u00e0 combler ce manque de donn\u00e9es et servir de point de d\u00e9part \u00e0 la conception de l\u2019\u00e9tude SAFIRE. \u00c0 l\u2019avenir, les donn\u00e9es probantes g\u00e9n\u00e9r\u00e9es par SAFIRE contribueront \u00e0 combler le manque d\u2019acc\u00e8s aux traitements pour les femmes atteintes de paludisme en d\u00e9but de grossesse tout en soutenant la conception de futurs essais ciblant d\u2019autres maladies infectieuses, en particulier celles qui touchent les femmes enceintes dans les pays \u00e0 revenu faible et interm\u00e9diaire.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f3a5b02 e-con-full e-flex e-con e-child\" data-id=\"f3a5b02\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-a424f16 e-con-full e-flex e-con e-child\" data-id=\"a424f16\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-85790d6 elementor-widget elementor-widget-heading\" data-id=\"85790d6\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Le Projet PYRAPREG<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-30820ac elementor-widget elementor-widget-text-editor\" data-id=\"30820ac\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Le <strong><a href=\"https:\/\/pyrapreg.org\/\" target=\"_blank\" rel=\"noopener\">projet PYRAPREG<\/a><\/strong>, financ\u00e9 par l\u2019EDCTP3, a \u00e9t\u00e9 lanc\u00e9 en 2019 afin de d\u00e9terminer l\u2019innocuit\u00e9, l\u2019efficacit\u00e9 et la pharmacocin\u00e9tique du m\u00e9dicament art\u00e9sunate-pyronaridine (AP) chez des femmes enceintes au cours de leur deuxi\u00e8me et troisi\u00e8me trimestres de grossesse et atteintes de paludisme \u00e0 <em>P. falciparum<\/em> non compliqu\u00e9 dans cinq pays africains.<\/p><p>PYRAPREG fournit les informations n\u00e9cessaires \u00e0 un <strong>traitement alternatif, s\u00fbr et efficace<\/strong> \u00e0 inclure dans les lignes directrices de l\u2019OMS sur le paludisme pendant la grossesse, contribuant ainsi \u00e0 r\u00e9duire la maladie chez les femmes enceintes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4afe029 e-con-full e-flex e-con e-child\" data-id=\"4afe029\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d385693 elementor-widget elementor-widget-image\" data-id=\"d385693\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"514\" src=\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg\" class=\"attachment-large size-large wp-image-756\" alt=\"\" srcset=\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg 1024w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-300x193.jpg 300w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-768x494.jpg 768w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP.jpg 1210w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4eb2feb e-con-full e-flex e-con e-child\" data-id=\"4eb2feb\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-e9a5e6d e-con-full e-flex e-con e-child\" data-id=\"e9a5e6d\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3042d0c elementor-widget elementor-widget-image\" data-id=\"3042d0c\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"773\" height=\"1024\" src=\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI13_Mother-and-baby-in-bednet-773x1024.jpg\" class=\"attachment-large size-large wp-image-754\" alt=\"\" srcset=\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI13_Mother-and-baby-in-bednet-773x1024.jpg 773w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI13_Mother-and-baby-in-bednet-227x300.jpg 227w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI13_Mother-and-baby-in-bednet-768x1017.jpg 768w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI13_Mother-and-baby-in-bednet-1160x1536.jpg 1160w, https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI13_Mother-and-baby-in-bednet.jpg 1430w\" sizes=\"(max-width: 773px) 100vw, 773px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-49976a9 e-con-full e-flex e-con e-child\" data-id=\"49976a9\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c1eec7e elementor-widget elementor-widget-heading\" data-id=\"c1eec7e\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">La Strat\u00e9gie MiMBa<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-21ec412 elementor-widget elementor-widget-text-editor\" data-id=\"21ec412\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Pour inclure davantage les femmes enceintes dans l&rsquo;approche actuelle du d\u00e9veloppement de m\u00e9dicaments, Medicines for Malaria Venture (MMV) a lanc\u00e9 la strat\u00e9gie \u2018<strong>Malaria in Mothers and Babies<\/strong>\u2019 (MiMBa) pour aider \u00e0 am\u00e9liorer l&rsquo;acc\u00e8s aux traitements actuels tout en fa\u00e7onnant des processus de R&amp;D inclusifs qui acc\u00e9l\u00e8rent le d\u00e9veloppement et l&rsquo;adaptation d&rsquo;antipaludiques vitaux pour les femmes enceintes et allaitantes.<\/p><p>Dans le cadre de la strat\u00e9gie MiMBa, MMV et la Liverpool School of Tropical Medicine (LSTM) ont lanc\u00e9 un <strong><a href=\"https:\/\/www.lstmed.ac.uk\/MiMBa#:~:text=The%20Malaria%20in%20Mothers%20and,focus%20on%20the%20first%20trimester\" target=\"_blank\" rel=\"noopener\">registre d&rsquo;exposition pendant la grossesse<\/a><\/strong> dans plusieurs pays, qui sert de base \u00e0 une \u00e9tude observationnelle visant \u00e0 g\u00e9n\u00e9rer des donn\u00e9es de s\u00e9curit\u00e9 robustes quant \u00e0 l&rsquo;utilisation de combinaisons th\u00e9rapeutiques \u00e0 base d&rsquo;art\u00e9misinine (CTA) antipaludiques pendant la grossesse, en mettant l&rsquo;accent sur le premier trimestre.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>En 2022, l\u2019Organisation Mondiale de la Sant\u00e9 a r\u00e9vis\u00e9 ses lignes directrices pour recommander l\u2019art\u00e9m\u00e9ther-lum\u00e9fantrine (AL) plut\u00f4t que la quinine comme traitement privil\u00e9gi\u00e9 du paludisme non compliqu\u00e9 au cours du premier trimestre de la grossesse. N\u00e9anmoins, la s\u00e9curit\u00e9 et l\u2019efficacit\u00e9 d\u2019autres traitements combin\u00e9s \u00e0 base d\u2019art\u00e9misinine fr\u00e9quemment utilis\u00e9s restent sous-\u00e9tudi\u00e9es, ce qui pr\u00e9sente un manque [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1012","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notre histoire - SAFIRE - Safety of Antimalarials in FIRst trimEster<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/safire-consortium.org\/about\/our-story\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notre histoire - SAFIRE - Safety of Antimalarials in FIRst trimEster\" \/>\n<meta property=\"og:description\" content=\"En 2022, l\u2019Organisation Mondiale de la Sant\u00e9 a r\u00e9vis\u00e9 ses lignes directrices pour recommander l\u2019art\u00e9m\u00e9ther-lum\u00e9fantrine (AL) plut\u00f4t que la quinine comme traitement privil\u00e9gi\u00e9 du paludisme non compliqu\u00e9 au cours du premier trimestre de la grossesse. N\u00e9anmoins, la s\u00e9curit\u00e9 et l\u2019efficacit\u00e9 d\u2019autres traitements combin\u00e9s \u00e0 base d\u2019art\u00e9misinine fr\u00e9quemment utilis\u00e9s restent sous-\u00e9tudi\u00e9es, ce qui pr\u00e9sente un manque [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/safire-consortium.org\/about\/our-story\/\" \/>\n<meta property=\"og:site_name\" content=\"SAFIRE\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-14T11:09:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1210\" \/>\n\t<meta property=\"og:image:height\" content=\"778\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/safire-consortium.org\/about\/our-story\/\",\"url\":\"https:\/\/safire-consortium.org\/about\/our-story\/\",\"name\":\"Notre histoire - SAFIRE - Safety of Antimalarials in FIRst trimEster\",\"isPartOf\":{\"@id\":\"https:\/\/safire-consortium.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/safire-consortium.org\/about\/our-story\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/safire-consortium.org\/about\/our-story\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg\",\"datePublished\":\"2024-09-30T14:16:42+00:00\",\"dateModified\":\"2025-01-14T11:09:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/safire-consortium.org\/about\/our-story\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/safire-consortium.org\/about\/our-story\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/safire-consortium.org\/about\/our-story\/#primaryimage\",\"url\":\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg\",\"contentUrl\":\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/safire-consortium.org\/about\/our-story\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/safire-consortium.org\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notre histoire\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/safire-consortium.org\/#website\",\"url\":\"https:\/\/safire-consortium.org\/\",\"name\":\"SAFIRE\",\"description\":\"Safety of Antimalarials in FIRst trimEster\",\"publisher\":{\"@id\":\"https:\/\/safire-consortium.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/safire-consortium.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/safire-consortium.org\/#organization\",\"name\":\"SAFIRE\",\"url\":\"https:\/\/safire-consortium.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/safire-consortium.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/09\/safire_logo.svg\",\"contentUrl\":\"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/09\/safire_logo.svg\",\"caption\":\"SAFIRE\"},\"image\":{\"@id\":\"https:\/\/safire-consortium.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notre histoire - SAFIRE - Safety of Antimalarials in FIRst trimEster","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/safire-consortium.org\/about\/our-story\/","og_locale":"fr_FR","og_type":"article","og_title":"Notre histoire - SAFIRE - Safety of Antimalarials in FIRst trimEster","og_description":"En 2022, l\u2019Organisation Mondiale de la Sant\u00e9 a r\u00e9vis\u00e9 ses lignes directrices pour recommander l\u2019art\u00e9m\u00e9ther-lum\u00e9fantrine (AL) plut\u00f4t que la quinine comme traitement privil\u00e9gi\u00e9 du paludisme non compliqu\u00e9 au cours du premier trimestre de la grossesse. N\u00e9anmoins, la s\u00e9curit\u00e9 et l\u2019efficacit\u00e9 d\u2019autres traitements combin\u00e9s \u00e0 base d\u2019art\u00e9misinine fr\u00e9quemment utilis\u00e9s restent sous-\u00e9tudi\u00e9es, ce qui pr\u00e9sente un manque [&hellip;]","og_url":"https:\/\/safire-consortium.org\/about\/our-story\/","og_site_name":"SAFIRE","article_modified_time":"2025-01-14T11:09:28+00:00","og_image":[{"width":1210,"height":778,"url":"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/safire-consortium.org\/about\/our-story\/","url":"https:\/\/safire-consortium.org\/about\/our-story\/","name":"Notre histoire - SAFIRE - Safety of Antimalarials in FIRst trimEster","isPartOf":{"@id":"https:\/\/safire-consortium.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/safire-consortium.org\/about\/our-story\/#primaryimage"},"image":{"@id":"https:\/\/safire-consortium.org\/about\/our-story\/#primaryimage"},"thumbnailUrl":"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg","datePublished":"2024-09-30T14:16:42+00:00","dateModified":"2025-01-14T11:09:28+00:00","breadcrumb":{"@id":"https:\/\/safire-consortium.org\/about\/our-story\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/safire-consortium.org\/about\/our-story\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/safire-consortium.org\/about\/our-story\/#primaryimage","url":"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg","contentUrl":"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/10\/PMI10_Pregnant-woman-taking-IPTP-1024x658.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/safire-consortium.org\/about\/our-story\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/safire-consortium.org\/fr\/"},{"@type":"ListItem","position":2,"name":"Notre histoire"}]},{"@type":"WebSite","@id":"https:\/\/safire-consortium.org\/#website","url":"https:\/\/safire-consortium.org\/","name":"SAFIRE","description":"Safety of Antimalarials in FIRst trimEster","publisher":{"@id":"https:\/\/safire-consortium.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/safire-consortium.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/safire-consortium.org\/#organization","name":"SAFIRE","url":"https:\/\/safire-consortium.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/safire-consortium.org\/#\/schema\/logo\/image\/","url":"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/09\/safire_logo.svg","contentUrl":"https:\/\/safire-consortium.org\/wp-content\/uploads\/2024\/09\/safire_logo.svg","caption":"SAFIRE"},"image":{"@id":"https:\/\/safire-consortium.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/pages\/1012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/comments?post=1012"}],"version-history":[{"count":13,"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/pages\/1012\/revisions"}],"predecessor-version":[{"id":1699,"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/pages\/1012\/revisions\/1699"}],"wp:attachment":[{"href":"https:\/\/safire-consortium.org\/fr\/wp-json\/wp\/v2\/media?parent=1012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}